143 related articles for article (PubMed ID: 12113544)
1. Hepatocyte protection by a protease inhibitor against ischemia/reperfusion injury of human liver.
Kim YI; Hwang YJ; Song KE; Yun YK; Lee JW; Chun BY
J Am Coll Surg; 2002 Jul; 195(1):41-50. PubMed ID: 12113544
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a protease inhibitor in the prevention of ischemia and reperfusion injury in hepatectomy under intermittent Pringle maneuver.
Kim YI; Chung HJ; Song KE; Hwang YJ; Lee JW; Lee YJ; Chun BY
Am J Surg; 2006 Jan; 191(1):72-6. PubMed ID: 16399110
[TBL] [Abstract][Full Text] [Related]
3. Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation.
Harada N; Okajima K; Kushimoto S
Crit Care Med; 1999 Sep; 27(9):1958-64. PubMed ID: 10507625
[TBL] [Abstract][Full Text] [Related]
4. Successful intermittent application of the Pringle maneuver for 30 minutes during human hepatectomy: a clinical randomized study with use of a protease inhibitor.
Kim YI; Fujita S; Hwang YJ; Chun JM; Song KE; Chun BY
Hepatogastroenterology; 2007; 54(79):2055-60. PubMed ID: 18251159
[TBL] [Abstract][Full Text] [Related]
5. Effects of a protease inhibitor on reduction of surgical stress in esophagectomy.
Ono S; Aosasa S; Mochizuki H
Am J Surg; 1999 Jan; 177(1):78-82. PubMed ID: 10037314
[TBL] [Abstract][Full Text] [Related]
6. Effect of synthetic protease inhibitor gabexate mesilate on the attenuation of ischemia/reperfusion injury in canine kidney autotransplantation.
Inoue S; Sugitani A; Yamamoto H; Kitada H; Motoyama K; Okabe Y; Ohta M; Yoshida J; Nishiyama K; Tanaka M
Surgery; 2005 Feb; 137(2):216-24. PubMed ID: 15674204
[TBL] [Abstract][Full Text] [Related]
7. Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats.
Mikami K; Goto T; Miura K; Ohshima S; Yoneyama K; Lin JG; Watanabe D; Segawa D; Kataoka E; Shibuya T; Watanabe S
J Gastroenterol; 2005 Mar; 40(3):260-5. PubMed ID: 15830285
[TBL] [Abstract][Full Text] [Related]
8. Enhanced inflammatory cytokine production at ischemia/reperfusion in human liver resection.
Kim YI; Song KE; Ryeon HK; Hwang YJ; Yun YK; Lee JW; Chun BY
Hepatogastroenterology; 2002; 49(46):1077-82. PubMed ID: 12143206
[TBL] [Abstract][Full Text] [Related]
9. Effects of gabexate mesilate on ischemia-reperfusion-induced testicular injury in rats.
Gezici A; Ozturk H; Buyukbayram H; Ozturk H; Okur H
Pediatr Surg Int; 2006 May; 22(5):435-41. PubMed ID: 16557390
[TBL] [Abstract][Full Text] [Related]
10. [The protective effect of Xuebijing injection pretreatment on hepatic ischemia reperfusion injury and coagulopathy after excision of liver cancer].
Shen J; Lin XJ; Cui BK; Chi PD; Zeng QY; Zhao QY
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Dec; 25(12):743-8. PubMed ID: 24620386
[TBL] [Abstract][Full Text] [Related]
11. Effect of protease inhibitor on ischemia-reperfusion injury to rat liver.
Jung SE; Yun IJ; Youn YK; Lee JE; Ha J; Noh DY; Kim SJ; Oh SK; Choe KJ
World J Surg; 1999 Oct; 23(10):1027-31. PubMed ID: 10512942
[TBL] [Abstract][Full Text] [Related]
12. Effects of gabexate mesilate (FOY) on ischemia-reperfusion-induced acute lung injury in dogs.
Luh SP; Tsai CC; Shau WY; Chen JS; Kuo SH; Lin-Shiau SY; Lee YC
J Surg Res; 1999 Dec; 87(2):152-63. PubMed ID: 10600344
[TBL] [Abstract][Full Text] [Related]
13. Gabexate mesilate, a synthetic protease inhibitor, attenuates endotoxin-induced pulmonary vascular injury by inhibiting tumor necrosis factor production by monocytes.
Murakami K; Okajima K; Uchiba M; Okabe H; Takatsuki K
Crit Care Med; 1996 Jun; 24(6):1047-53. PubMed ID: 8681572
[TBL] [Abstract][Full Text] [Related]
14. Cytokine response to human liver ischemia-reperfusion injury during hepatectomy: marker of injury or surgical stress?
Hanazaki K; Monma T; Hiraguri M; Ohmoto Y; Kajikawa S; Matsushita A; Nimura Y; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2001; 48(37):188-92. PubMed ID: 11268962
[TBL] [Abstract][Full Text] [Related]
15. Lack of therapeutic effects of gabexate mesilate on the hepatic encephalopathy in rats with acute and chronic hepatic failure.
Hsu CY; Lee FY; Huo TI; Chan CY; Huang HC; Lin HC; Chang CC; Teng TH; Wang SS; Lee SD
J Gastroenterol Hepatol; 2010 Jul; 25(7):1321-8. PubMed ID: 20594263
[TBL] [Abstract][Full Text] [Related]
16. Gabexate mesilate inhibits the expression of HMGB1 in lipopolysaccharide-induced acute lung injury.
Hidaka S; Iwasaka H; Hagiwara S; Noguchi T
J Surg Res; 2011 Jan; 165(1):142-50. PubMed ID: 19766246
[TBL] [Abstract][Full Text] [Related]
17. Gabexate mesilate, a new synthetic serine protease inhibitor: a pilot clinical trial in valvular heart surgery.
Parodi F; Cordero G; De Gasperis C; Minola P; Dellora C; Innocenti P
J Cardiothorac Vasc Anesth; 1996 Feb; 10(2):235-7. PubMed ID: 8850404
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine exerts a protective effect on ischemia-reperfusion injury after hepatectomy: A prospective, randomized, controlled study.
Zhang Y; Liu M; Yang Y; Cao J; Mi W
J Clin Anesth; 2020 May; 61():109631. PubMed ID: 31669050
[TBL] [Abstract][Full Text] [Related]
19. Increased serum levels of soluble tumor necrosis factor a-receptors in patients undergoing partial liver resection.
Schroder J; Gallati H; Kremer B
Hepatogastroenterology; 1998; 45(23):1807-12. PubMed ID: 9840152
[TBL] [Abstract][Full Text] [Related]
20. Cytokines contribute to early hepatic parenchymal injury and microvascular dysfunction after bilateral hindlimb ischemia.
Lawlor DK; Brock RW; Harris KA; Potter RF
J Vasc Surg; 1999 Sep; 30(3):533-41. PubMed ID: 10477647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
